HAEM5:Gamma heavy chain disease: Difference between revisions
| [unchecked revision] | [unchecked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
{{Under Construction}} | {{Under Construction}} | ||
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023- | <blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Gamma Heavy Chain Disease]]. | ||
}}</blockquote> | }}</blockquote> | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
| Line 19: | Line 19: | ||
==Cancer Category / Type== | ==Cancer Category / Type== | ||
*[[Mature B-Cell Neoplasms]] | *[[HAEM4:Mature B-Cell Neoplasms]] | ||
==Cancer Sub-Classification / Subtype== | ==Cancer Sub-Classification / Subtype== | ||
| Line 355: | Line 355: | ||
Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm | Some cases of gamma-HCD (γ-HCD) are concurrent with other lymphoid neoplasm have been reported in the literature and are listed below; treatment option varies with concurrent neoplasm | ||
*[[Chronic | *[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)]] | ||
*DLBCL-diffuse large B cell Lymphoma | *DLBCL-diffuse large B cell Lymphoma | ||
*LCPD-lymphoplasma cell proliferative disorder | *LCPD-lymphoplasma cell proliferative disorder | ||
*[[Lymphoplasmacytic | *[[HAEM5:Lymphoplasmacytic lymphoma|Lymphoplasmacytic Lymphoma (LPL]]) | ||
*MALT -mucosa-associated lymphoid tissue | *MALT -mucosa-associated lymphoid tissue | ||
*MDS-myelodysplastic syndrome | *MDS-myelodysplastic syndrome | ||